HCPLive Network

Perceived Weight Gain Accurate for New Contraceptive Users

 
TUESDAY, Jan. 22 (HealthDay News) -- For new contraceptive users, perceived weight gain, reported by about one-third of users, often represents actual weight gain, according to a study published in the January issue of the American Journal of Obstetrics & Gynecology.

Ashley M. Nault, from the Washington University School of Medicine in St. Louis, and colleagues analyzed self-reported weight change data from 4,133 new contraceptive method users at three, six, and 12 months after enrollment. To assess the validity of self-reported weight gain, data were examined for a subgroup of participants with objective weight measurements at baseline and 12 months.

The researchers found that weight gain was perceived by 34 percent of participants. Implant users and depot medroxyprogesterone acetate users were more likely to report perceived weight gain than copper intrauterine device users (relative risk, 1.29 and 1.37, respectively). There was a mean actual weight gain of 10.3 pounds in women who perceived weight gain. The sensitivity of perceived weight gain was 74.6 percent and the specificity was 84.4 percent.

"In conclusion, self-reported weight change is easy to obtain and in most women represents true weight gain," the authors write. "The perception of weight gain is clinically important because it may affect a woman's satisfaction with her contraceptive method or influence a woman's decision to continue the use of the method."

Two authors disclosed financial ties to the pharmaceutical industry.
 

Abstract
Full Text


Copyright © 2013 HealthDay. All rights reserved.
 
 

Further Reading
Researchers at Hong Kong University and the Wellcome Trust Sanger Institute have identified a link between the influenza A viruses’ genetic diversity and severity of the infection.
Carol Burke, MD, FACG, FASGE, talks about her phase-3 placebo-controlled trial of Celecoxib in pediatric subjects with familial adenomatous polyposis (FAP) at the 2014 ACG Annual Meeting in Philadelphia, PA.
Carol Burke, MD, FACG, FASGE, discusses pediatric familial adenomatous polyposis (FAP) and colorectal cancer at the 2014 ACG Annual Scientific Meeting in Philadelphia, PA.
The immune system is the new focus of much work on traumatic brain injury (TBI). In a challenge to the paradigm that the blood brain barrier prevents harmful leukocytes from entering the brain, a Texas team tried to neutralize the impact of these cells. Peripheral lymphocytes are activated after TBI. They may then act as potential antigen presenting cells and get into the brain, causing cells there to degenerate.
Increasing use of hospice in the final days of ovarian cancer does not offset intensive end-of-life care in older women, according to a study published online Oct. 6 in the Journal of Clinical Oncology.
The CDC announces monitoring for all passengers from 3 Ebola-stricken nations, part of increased surveillance efforts as new Ebola czar Ron Klain starts firs day of work. Meanwhile, Bentley, the dog confined because his owner Dallas nurse Nina Pham has the virus, is cleared to go home. NBC medical editor Nancy Snyderman released from her Princeton, NJ home quarantine, and the NBC cameraman stricken with the disease is now Ebola-free.
Drug coupons could reduce patients' out-of-pocket costs by 60 percent, according to a study published in the October issue of Health Affairs.
More Reading